EXAS News and Press, Exact Sciences Corporation From 05/24/24

Data to be presented expands the body of evidence around the predictive and prognostic value of the Oncotype DX ® test in all racial and ethnic groups New data showcase Exact Sciences’ commitment to innovation and strategies that expand access to effective cancer screening and...

2024-05-23 17:05:39 ET More on Guardant Health Guardant Health slips as FDA comments on cancer screening test Guardant Health: Shield Launch Could Drive Multiple Expansion Guardant Health, Inc. (GH) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quan...

2024-05-23 08:39:07 ET More on Guardant Health Guardant Health, Inc. (GH) Q1 2024 Earnings Call Transcript Guardant Health: Shield Launch Could Drive Multiple Expansion Guardant Health slips as FDA comments on cancer screening test Guardant Health Non-GAAP EP...

Award marks sixth consecutive year company has received prestigious distinction Exact Sciences (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today that the company has been certified as a 2024 Great Place To Work® for the sixth consecuti...

2024-05-21 11:05:08 ET More on Guardant Health Guardant Health, Inc. (GH) Q1 2024 Earnings Call Transcript Guardant Health: Shield Launch Could Drive Multiple Expansion Guardant Health, Inc. (GH) Q4 2023 Earnings Call Transcript Guardant Health Non-GAAP EPS o...

2024-05-21 10:36:37 ET More on Exact Sciences Exact Sciences: Cancer Battle Continues, Shares Likely To Plateau Most attractive short-term overwriting stocks for June expiration - Goldman Exact Sciences down 17% on quarterly bottom line miss, maintaining 2024 guidanc...

Company asserts that Geneoscopy will infringe patented technology central to its Cologuard colorectal cancer screening test Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that a District Court judge denied in part Geneosco...

2024-05-20 20:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) fell 28.8% to $0.171 on volume of 1,679,698,404 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 37.6% to $1.03 on volume of 1,254,842,792 shares Greenwave Technology Solutions Inc. (GWAV)...

A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 110.4% to $0.505 on volume of 466,339,579 shares Greenwave Technology Solutions Inc. (GWAV) rose 59.1% to $0.2356 on volume of 260,628,040 shares Faraday Future Intelligent Electric Inc. (FFIE) ...